Erudio Healtherudio.com
Drug
NeoVax trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying neoVax: NCT02950766. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| NCT02950766 NCT02950766 · Patrick Ott, MD, PhD | high-risk renal cell carcinoma | Phase 1 | 115 | 23 | Focused | Nov 21, 2026 | Preview |